Not applicableStudy completedNCT01202565
What this trial is testing
Effectiveness of Adalimumab (HUMIRA®) in the Treatment of Scalp and Nail Affection in Patients With Moderate to Severe Plaque Psoriasis in Routine Clinical Practice
Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie (prior sponsor, Abbott) 506